Coopération entre des bactéries solubilisatrices de phosphate et le champignon mycorhizien à arbuscule Rhizophagus irregularis dans la nutrition phosphatée de la pomme de terre

National audienceLe phosphore est un élément essentiel pour le développement des plantes. Néanmoins, la majorité des ions phosphate est incorporée dans des structures organiques (Po) et inorganiques (Pi) insolubles qui rende cet élément très peu disponible pour les plantes et en particulier pour la pomme de terre (Solanum tuberosum). Dans les sols, le phytate (molécule de réserve phosphatée des plantes), est une source essentielle. Pour accéder au phosphate, les plantes ont développé des symbioses mutualistes à bénéfices réciproques avec des microorganismes de la rhizosphère capables d’extraire le P. Dans ce contexte, les objectifs de cette étude étaient de i) déterminer si la disponibilité en P du sol impacte la distribution des communautés bactériennes efficaces pour mobiliser le P et ii) développer des associations contrôlées tripartites entre plante/champignon mycorhizien et souche bactérienne efficace pour mobiliser le P. Un total de 185 souches bactériennes provenant de trois sols caractérisés par des concentrations en phosphate total différentes ont été caractérisées sur leur capacité à rompre des complexes de Po (phytate) et de Pi (Tricalcique phosphate) ainsi à acidifier. Cette étude a révélé que la concentration en phosphate libre d’un sol affecte la fréquence et l’efficacité des communautés bactériennes capables de dégrader le phytate. La souche bactérienne 11.2B affiliée au genre Erwinia est apparue comme la plus efficace dans cette fonction de solubilisation. La comparaison des résultats issus des différents biotests suggère que la solubilisation du phytate dans nos collections serait essentiellement due à une acidification, plutôt qu’à une activité phytase strictement. Un protocole expérimental visant à associer S. tuberosum, le champignon mycorhizien à arbuscule Rhizophagus irregularis et la souche 11.2B a été développé in vitro. Ce modèle expérimental a pour but d’analyser in fine l’impact de ces deux microorganismes symbiotiques sur la nutrition phosphatée du plant de pomme de terre

Persistent headaches one year after bacterial meningitis: prevalence, determinants and impact on quality of life

International audienceBackground: Little is known on headaches long-term persistence after bacterial meningitis and on their impact on patients' quality of life.Methods: In an ancillary study of the French national prospective cohort of community-acquired bacterial meningitis in adults (COMBAT) conducted between February 2013 and July 2015, we collected self-reported headaches before, at onset, and 12 months (M12) after meningitis. Determinants of persistent headache (PH) at M12, their association with M12 quality of life (SF 12), depression (Center for Epidemiologic Studies Depression Scale) and neuro-functional disability were analysed.Results: Among the 277 alive patients at M12 87/274 (31.8%), 213/271 (78.6%) and 86/277 (31.0%) reported headaches before, at the onset, and at M12, respectively. In multivariate analysis, female sex (OR: 2.75 [1.54-4.90]; p < 0.001), pre-existing headaches before meningitis (OR: 2.38 [1.32-4.30]; p < 0.01), higher neutrophilic polynuclei percentage in the CSF of the initial lumbar puncture (OR: 1.02 [1.00-1.04]; p < 0.05), and brain abscess during the initial hospitalisation (OR: 8.32 [1.97-35.16]; p < 0.01) were associated with M12 persistent headaches. Neither the responsible microorganism, nor the corticoids use were associated with M12 persistent headaches. M12 neuro-functional disability (altered Glasgow Outcome Scale; p < 0.01), M12 physical handicap (altered modified Rankin score; p < 0.001), M12 depressive symptoms (p < 0.0001), and M12 altered physical (p < 0.05) and mental (p < 0.0001) qualities of life were associated with M12 headaches.Conclusion: Persistent headaches are frequent one year after meningitis and are associated with quality of life alteration

One-Year Sequelae and Quality of Life in Adults with Meningococcal Meningitis: Lessons from the COMBAT Multicentre Prospective Study

Trial registration: ClinicalTrial.Gov identification number NCT01730690.International audienceIntroduction: COMBAT is a prospective, multicentre cohort study that enrolled consecutive adults with community-acquired bacterial meningitis (CABM) in 69 participating centres in France between February 2013 and July 2015 and followed them for 1 year.Methods: Patients aged at least 18 years old, hospitalised with CABM were followed during their hospitalisation and then contacted by phone 12 months after enrolment. Here we present the prevalence of sequelae at 12 months in a subgroup of patients with meningococcal meningitis.Results: Five of the 111 patients with meningococcal meningitis died during initial hospitalisation and two died between discharge and 12 months, leaving 104 patients alive 1 year after enrolment, 71 of whom provided 12-month follow-up data. The median age was 30.0 years and 54.1% of the patients had no identified risk factor for meningitis. More than 30% reported persistent headache, more than 40% were not satisfied with their sleep and 10% had concentration difficulties. Hearing loss was present in about 15% of the patients and more than 30% had depressive symptoms. About 13% of the patients with a previous professional activity had not resumed work. On the SF-12 Health Survey, almost 50% and 30% had physical component or mental component scores lower than the 25th percentile of the score distribution in the French general population. There was a non-significant improvement in the patients' disability scores from hospital discharge to 12 months (p = 0.16), but about 10% of the patients had residual disability.Conclusions: Although most patients in our cohort survive meningococcal meningitis, the long-term burden is substantial and therefore it is important to ensure a prolonged follow-up of survivors and to promote preventive strategies, including vaccination

Relationship between serotypes, disease characteristics and 30-day mortality in adults with invasive pneumococcal disease

International audienc